Thrombocytopenia Associated With Chronic Liver Disease: Effects of Rifaximin on Platelet Count

被引：6
|
作者：
Kalambokis, Georgios [1 ]
Tsianos, Epameinondas V. [1 ]
机构：
[1] Univ Hosp, Div Internal Med & Hepatogastroenterol 1, Ioannina, Greece
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2010年 / 105卷 / 12期
关键词：
NITRIC-OXIDE PATHWAY; PATHOGENESIS; CIRRHOSIS;
D O I：
10.1038/ajg.2010.364
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2705 / 2707
页数：5
相关论文
共 50 条
  • [1] CORRELATION OF PLATELET COUNT WITH ENDOTOXAEMIA IN CIRRHOTIC PATIENTS WITH THROMBOCYTOPENIA AND EFFECTS OF RIFAXIMIN
    Kalambokis, G.
    Mouzaki, A.
    Rodi, M.
    Tsianos, E.
    [J]. JOURNAL OF HEPATOLOGY, 2011, 54 : S71 - S71
  • [2] Platelet kinetics in chronic liver disease associated with thrombocytopenia.
    Noguchi, H
    Yoshida, T
    Yoshiyama, Y
    Ijuin, H
    Kajiwara, M
    Itano, S
    Sakata, K
    Ono, N
    Sata, M
    Tanikawa, K
    [J]. HEPATOLOGY, 1996, 24 (04) : 1715 - 1715
  • [3] Role of severe thrombocytopenia in preventing platelet count recovery in thrombocytopenic patients with chronic liver disease
    Hirooka, Masashi
    Ochi, Hironori
    Hiraoka, Atsushi
    Koizumi, Yohei
    Tanaka, Takaaki
    Sunago, Kotaro
    Yukimoto, Atsushi
    Imai, Yusuke
    Watanabe, Takao
    Yoshida, Osamu
    Abe, Masanori
    Joko, Kouji
    Michitaka, Kojiro
    Hiasa, Yoichi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (02) : 299 - 304
  • [4] The burden associated with thrombocytopenia and platelet transfusions among patients with chronic liver disease
    Elsaid, Mohamed, I
    Rustgi, Vinod K.
    Loo, Nicole
    Aggarwal, Kavita
    Li-McLeod, Josephine
    Niu, Xiaoli
    Poordad, Fred
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 378 - 385
  • [5] Thrombocytopenia associated with chronic liver disease
    Afdhal, Nezam
    McHutchison, John
    Brown, Robert
    Jacobson, Ira
    Manns, Michael
    Poordad, Fred
    Weksler, Babette
    Esteban, Rafael
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (06) : 1000 - 1007
  • [6] Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease
    Michelson, A. D.
    Koganov, E. Smolensky
    Forde, E. E.
    Carmichael, S. L.
    Frelinger, A. L., III
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) : 2515 - 2519
  • [7] Risk Factors for Transition From Normal Platelet Count to Severe Thrombocytopenia Among Patients with Chronic Liver Disease
    Lawler, Elizabeth V.
    Fonda, Jennifer R.
    Horblyuk, Ruslan V.
    Grotzinger, Kelly M.
    McLaughlin, Cara
    Morgan, Tim
    Pedrosa, Marcos
    Gagnon, David R.
    [J]. BLOOD, 2009, 114 (22) : 1365 - 1365
  • [8] Platelet satellitism: a spurious cause of thrombocytopenia in chronic liver disease
    Sultan, Sadia
    Irfan, Syed Muhammad
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (01) : 90 - 91
  • [9] Mechanisms for increment of platelet associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease
    Doi, T
    Homma, H
    Mezawa, S
    Kato, J
    Kogawa, K
    Sakamaki, S
    Niitsu, Y
    [J]. HEPATOLOGY RESEARCH, 2002, 24 (01) : 23 - 33
  • [10] DETERMINATION OF THE CHALLENGES AND OPPORTUNITIES ASSOCIATED WITH PLATELET TRANSFUSION IN THE MANAGEMENT OF PATIENTS WITH SEVERE THROMBOCYTOPENIA ASSOCIATED WITH CHRONIC LIVER DISEASE
    Jarque, Ramos, I
    Mingot, Castellano M. E.
    Anguita, Velasco J.
    Fernandez, Herrera M. D.
    Larrea, Gonzalez L.
    Richart, Lopez L. A.
    Garcia, Labrador L.
    Subias, Labazuy S.
    Shepherd, Moreno J.
    [J]. HAEMATOLOGICA, 2020, 105 : 376 - 377
12345